|Articles|February 10, 2023

SCOPE 2023: Synopsis of Biospecimen Sample Management Presentation

Hope Meely, chief clinical officer at Slope, provides a brief summary of her SCOPE presentation revolving around biospecimen collection.

In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Hope Meely, chief clinical officer at Slope, explains why biospecimens within the precision and personalized medicine spaces have become so valuable. Meely is coming off her conference presentation, "The Hidden Regulatory Risk from Sample Management — What Should You Be Aware of?”

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content